KIR3DL2 and COVID-19: Consistent with these findings, we observed a significantly decreased frequency of KIR3DL1+HLA-Bw4+ and KIR3DL2+HLA-A3/11+ gene combinations in hospitalized COVID-19 patients suggesting a protective role for these inhibitory KIR-HLA gene combinations to COVID-19.